Name : SAB Biotherapeutics, Inc
Current / Former Name: SAB Biotherapeutics, Inc (Current)
Address: 2111 S. Western Ave, Sioux Falls, SD 57105
Phone Number: (605) 543-5292
Investor Relations Contact: ir@sabbiotherapeutics.com
Website - https://www.sabbiotherapeutics.com
Warrant Details
Warrant Symbol: SABSW
Warrants Listed: 10,410,000
Ratio: 1-for-1
Cusip Number: 78474N 11 0
ISIN Number: US78474N1107
Parent Stock Symbol: SABS (NASDAQ)
Underlying Stock Cusip: 78474N 10 2
Expiry Date - October 22, 2026
Exercise Price: $11.50 USD
Synopsis & Listing Information
SAB Biotherapeutics is a clinical-stage biopharmaceutical company.
Listing History: The company’s IPO closed in October 2021 via merger with Big Cypress Acquisition Corp. The warrants began separate trading on the Nasdaq under the symbol SABSW.
Current Status: As of June 2026, the warrants remain active on the Nasdaq and are set to expire on October 22, 2026.
Current / Former Name: SAB Biotherapeutics, Inc (Current)
Address: 2111 S. Western Ave, Sioux Falls, SD 57105
Phone Number: (605) 543-5292
Investor Relations Contact: ir@sabbiotherapeutics.com
Website - https://www.sabbiotherapeutics.com
Warrant Details
Warrant Symbol: SABSW
Warrants Listed: 10,410,000
Ratio: 1-for-1
Cusip Number: 78474N 11 0
ISIN Number: US78474N1107
Parent Stock Symbol: SABS (NASDAQ)
Underlying Stock Cusip: 78474N 10 2
Expiry Date - October 22, 2026
Exercise Price: $11.50 USD
Synopsis & Listing Information
SAB Biotherapeutics is a clinical-stage biopharmaceutical company.
Listing History: The company’s IPO closed in October 2021 via merger with Big Cypress Acquisition Corp. The warrants began separate trading on the Nasdaq under the symbol SABSW.
Current Status: As of June 2026, the warrants remain active on the Nasdaq and are set to expire on October 22, 2026.
American Financial News
Loading the latest American market news...
American Financial News
Loading the latest American market news...